Anavex Life Sciences
AVXL
#7299
Rank
ยฃ0.32 B
Marketcap
ยฃ3.50
Share price
-0.22%
Change (1 day)
-48.95%
Change (1 year)

Earnings for Anavex Life Sciences (AVXL)

Earnings in 2025 (TTM): -ยฃ35.68 Million

According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ38.94 Million a decrease over its 2023 earnings that were of -ยฃ33.93 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Anavex Life Sciences from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ35.68 Million-8.38%
2024 -ยฃ38.94 Million14.77%
2023 -ยฃ33.93 Million-17.49%
2022 -ยฃ41.12 Million22.96%
2021 -ยฃ33.44 Million35.36%
2020 -ยฃ24.71 Million12.65%
2019 -ยฃ21.93 Million29.09%
2018 -ยฃ16.99 Million36.33%
2017 -ยฃ12.47 Million17.11%
2016 -ยฃ10.65 Million20.91%
2015 -ยฃ8.81 Million-6.29%
2014 -ยฃ9.4 Million337.28%
2013 -ยฃ2.15 Million
2008 -ยฃ3.98 Million106.01%
2007 -ยฃ1.93 Million8848.98%
2006 -ยฃ0.03 Million-79.99%
2005 -ยฃ0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ligand Pharmaceuticals
LGND
ยฃ50.44 M-242.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
ยฃ49.52 M-240.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-ยฃ3.63 Million-89.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ5 Million-85.86%๐Ÿ‡บ๐Ÿ‡ธ USA